FdaApplication

NDA 215602

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAZURITY PHARMACEUTICALS INC
application_typeNDA
approval_date2022-02-04

Products (1)

ProductActive ingredientStrengthDosage form
FLEQSUVYBACLOFEN25MG/5MLSUSPENSION;ORAL

1 product